ABSTRACT
Management of hypertension in adults is guided by evidence derived from the results of large-scale clinical trials that have examined the Beects of specic antihypertensive agents on cardiovascular morbidity and mortality.1 In contrast, the management of hypertensive children and adolescents is still largely empiric. is is mainly because of the lack of long-term outcome data regarding the ecacy and safety of nonpharmacologic and pharmacologic approaches to treatment of hypertension in children and adolescents.2
